PER 1.41% 7.0¢ percheron therapeutics limited

Ann: Positive feedback received on Paediatric Investigation Plan, page-106

  1. 226 Posts.
    lightbulb Created with Sketch. 76
    Hey Uboy, all

    question....

    if Sarepta was to announce any kind of deal (licensing, partnership etc) with ANP in its update on its capital raising would this mean that ANP would have to request a trading halt prior to this happening ?

    Dave
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.